Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fix Price's LFL sales increased by 1.9% in the 1st half of the year

8/8/24 FIXP

VK reported for 6 months of 2024 by IFRS

8/8/24 VKCO

Sberbank reported for 6 months of 2024 by IFRS

8/8/24 SBER

Ozon launched sales in Azerbaijan

8/8/24 OZON

MTS launches additional share buyback from non-residents

8/8/24 MTSS

Board of Directors of Phosagro recommended that dividends

8/7/24 PHOR

PhosAgro reports for 6 months of 2024 by IFRS

8/7/24 PHOR

Fesco reported for 6 months of 2024 by RAS

8/7/24 FESH

Nauka-Svyaz reported for 6 months of 2024 by RAS

8/7/24 NSVZ

Number of installations of VK Video has grown to 250 thousand per day

8/7/24 VKCO